215.78
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VEEV Giù?
Forum
Previsione
Precedente Chiudi:
$210.08
Aprire:
$210.82
Volume 24 ore:
1.17M
Relative Volume:
0.96
Capitalizzazione di mercato:
$36.24B
Reddito:
$2.75B
Utile/perdita netta:
$714.14M
Rapporto P/E:
49.83
EPS:
4.33
Flusso di cassa netto:
$1.09B
1 W Prestazione:
-3.12%
1M Prestazione:
-8.87%
6M Prestazione:
-1.72%
1 anno Prestazione:
+8.40%
Veeva Systems Inc Stock (VEEV) Company Profile
Nome
Veeva Systems Inc
Settore
Industria
Telefono
925-452-6500
Indirizzo
4280 HACIENDA DRIVE, PLEASANTON, CA
Confronta VEEV con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
VEEV
Veeva Systems Inc
|
215.78 | 36.24B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
DOCS
Doximity Inc
|
52.40 | 9.99B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
43.23 | 7.43B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
83.45 | 7.20B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.45 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-23 | Downgrade | Goldman | Buy → Sell |
2024-12-20 | Iniziato | Stephens | Overweight |
2024-12-04 | Iniziato | Mizuho | Outperform |
2024-11-19 | Iniziato | Scotiabank | Sector Perform |
2024-10-08 | Iniziato | Exane BNP Paribas | Outperform |
2024-08-27 | Reiterato | Citigroup | Buy |
2024-07-09 | Iniziato | BTIG Research | Buy |
2023-10-25 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-10-13 | Iniziato | Jefferies | Buy |
2023-06-28 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2023-06-01 | Aggiornamento | Guggenheim | Neutral → Buy |
2023-03-17 | Downgrade | Truist | Buy → Hold |
2023-02-23 | Downgrade | Guggenheim | Buy → Neutral |
2023-01-04 | Aggiornamento | Barclays | Equal Weight → Overweight |
2022-12-06 | Iniziato | Cowen | Market Perform |
2022-12-02 | Reiterato | Needham | Buy |
2022-10-31 | Iniziato | Wells Fargo | Equal Weight |
2022-10-19 | Aggiornamento | JP Morgan | Underweight → Neutral |
2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
2022-07-27 | Iniziato | Oppenheimer | Outperform |
2022-06-23 | Iniziato | Goldman | Buy |
2022-06-21 | Ripresa | Guggenheim | Buy |
2022-03-03 | Downgrade | BofA Securities | Buy → Neutral |
2022-01-28 | Iniziato | Truist | Buy |
2022-01-07 | Downgrade | Stephens | Overweight → Equal-Weight |
2022-01-06 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
2021-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2021-10-01 | Ripresa | Stifel | Buy |
2021-09-02 | Reiterato | BofA Securities | Buy |
2021-09-02 | Reiterato | JMP Securities | Mkt Outperform |
2021-09-02 | Reiterato | Needham | Buy |
2021-09-02 | Reiterato | UBS | Neutral |
2021-07-21 | Iniziato | Cowen | Outperform |
2021-03-31 | Aggiornamento | UBS | Sell → Neutral |
2021-01-07 | Ripresa | KeyBanc Capital Markets | Overweight |
2020-12-09 | Downgrade | JP Morgan | Neutral → Underweight |
2020-10-14 | Ripresa | UBS | Sell |
2020-08-28 | Reiterato | Needham | Buy |
2020-07-23 | Iniziato | FBN Securities | Outperform |
2020-07-07 | Iniziato | Stephens | Overweight |
2020-06-08 | Iniziato | Citigroup | Buy |
2020-05-29 | Reiterato | Needham | Buy |
2020-04-13 | Iniziato | SVB Leerink | Mkt Perform |
2020-02-19 | Iniziato | Robert W. Baird | Outperform |
2020-02-14 | Iniziato | Piper Sandler | Overweight |
2020-01-13 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2019-11-27 | Reiterato | Canaccord Genuity | Hold |
2019-09-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2019-08-28 | Reiterato | Needham | Buy |
2019-06-07 | Iniziato | Goldman | Neutral |
2019-05-30 | Reiterato | BofA/Merrill | Buy |
2019-05-30 | Aggiornamento | Stephens | Equal-Weight → Overweight |
2019-05-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2019-04-17 | Reiterato | Needham | Buy |
2019-02-27 | Reiterato | Needham | Buy |
Mostra tutto
Veeva Systems Inc Borsa (VEEV) Ultime notizie
Zacks Industry Outlook Highlights Veeva Systems, Hims & Hers Health and Butterfly Network - Yahoo Finance
Life Science Data Needs an Upgrade: Veeva Has Answers - Fierce Pharma
Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock - MSN
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy? - Yahoo Finance
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next - The Motley Fool
Veeva Systems: Substantially Overvalued As Growth Slows (NYSE:VEEV) - Seeking Alpha
Veeva Systems (NYSE:VEEV) Partners With Flatiron To Enhance Clinical Trial Data Efficiency - Yahoo Finance
Flatiron Health Joins Veeva’s Product Partner Program to Accelerate Oncology Clinical Research - Business Wire
Q4 Earnings Outperformers: Veeva Systems (NYSE:VEEV) And The Rest Of The Vertical Software Stocks - Yahoo Finance
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Veeva Systems’ chief customer officer sells $265,168 in stock By Investing.com - Investing.com India
Veeva Systems’ chief customer officer sells $265,168 in stock - Investing.com
4 Ways Top Sponsors Build Strong and Sustainable Site Relationships - Veeva
Investors Interested In Veeva Systems Inc.'s (NYSE:VEEV) Earnings - simplywall.st
Improve Safety Outputs, Oversight, and Data Quality with In-house Pharmacovigilance Solution - Veeva
Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last? - Nasdaq
eClinical Solutions Market Top PlayersMedidata, Veeva Systems, Iqvia Inc., Icon Plc, Signant Health. - openPR.com
ACELYRIN Optimizes the Sponsor-CRO Data Flow with a Centralized Clinical Data Workbench - Veeva
Veeva Systems director Timothy Cabral sells $841,734 in stock By Investing.com - Investing.com Canada
Veeva Systems director Timothy Cabral sells $841,734 in stock - Investing.com
Veeva Systems (VEEV) Gains As Market Dips: What You Should Know - Yahoo Finance
Why Is Veeva (VEEV) Down 6.2% Since Last Earnings Report? - Yahoo Finance
Veeva Systems (VEEV) Benefited in Q4 From Strong Execution - Insider Monkey
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know - MSN
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks - Yahoo Finance
Best Momentum Stocks to Buy for April 3rd - TradingView
Veeva Systems Inc. (NYSE:VEEV) Receives $256.52 Average PT from Brokerages - MarketBeat
Veeva Systems SVP sells shares worth $178,019 - Investing.com Australia
Wall Street Analysts Think Veeva (VEEV) Is a Good Investment: Is It? - MSN
Veeva Systems SVP sells shares worth $178,019 By Investing.com - Investing.com Canada
We Think Veeva Systems' (NYSE:VEEV) Profit Is Only A Baseline For What They Can Achieve - Yahoo
VEEV Stock Slips Despite New Research Site Clinical Trial System - Yahoo Finance
How UCB and Other Biopharmas Made the Case for Safety Transformation - Veeva
Aligning Medical & Commercial Teams to Drive Product Adoption - Veeva
Veeva Systems (NYSE:VEEV) Unveils New CTMS for Efficient Clinical Trial Management - Yahoo Finance
Veeva Announces Research Site Clinical Trial Management System - Contract Pharma
5 Momentum Stocks to Buy for April Despite a Disappointing March - TradingView
Sell Rating for Veeva Systems Amid Volatile Macroeconomic Conditions and Industry Risks - TipRanks
EVERSANA joins with Veeva in push to 'pharmatise AI' - pharmaphorum
EVERSANA Joins Veeva AI Partner Program - PR Newswire
Top Stock Picks for Week of March 31, 2025 - TradingView
Veeva Systems’ SWOT analysis: cloud software leader faces industry headwinds - Investing.com
Here's Why You Should Add Veeva Systems Stock to Your Portfolio Now - MSN
China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market - Investor's Business Daily
What Does the Market Think About Veeva Systems? - Benzinga
Verve: Embracing Digital-First Quality - Veeva
Exponential Growth Expected for Clinical Data Management - openPR
Veeva Systems, Inc. is hiring: Creative Operations Manager in New York - Mediabistro
Veeva Systems Inc Azioni (VEEV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):